RISVAN
LIVE

Serial Number

79284764

Owner

LABORATORIOS FARMACEUTICOS; ROVI, S.A.

Filing Date

Apr 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RISVAN Trademark

Serial Number: 79284764 • Registration: 6177320

RISVAN is a trademark filed by LABORATORIOS FARMACEUTICOS; ROVI, S.A. on April 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LABORATORIOS FARMACEUTICOS; ROVI, S.A. (34 trademarks)

C/ Julián Camarillo, 35
MADRID E28037 , ES

Entity Type: 99

Trademark Details

Filing Date

April 14, 2020

Registration Date

October 20, 2020

Published for Opposition

August 4, 2020

Goods & Services

Pharmaceutical products, namely, tranquilizers, synthetic narcotics on prescription, antidepressants, anxiolytics, antipsychotics, chemical products for medical use being pharmaceutical products for schizophrenia treatment, chemical pharmaceuticals for treatment of central nervous system diseases, disposable syringes sold prefilled with pharmaceutical preparations for treatment of central nervous system diseases, preparations for treatment of central nervous system diseases, preparations for schizophrenia treatment

Filing History

NOTIFICATION PROCESSED BY IB
Dec 25, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 19, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 20, 2020 R.PR
PUBLISHED FOR OPPOSITION
Aug 4, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTICE OF PUBLICATION
Jul 15, 2020 NPUB
ASSIGNED TO LIE
Jul 2, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2020 CNSA
ASSIGNED TO EXAMINER
Jun 30, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 19, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 13, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 7, 2020 REPR